Red Blood Cells Flashcards
What is anaemia
Reduction in red cells or their haemoglobin. Theres multiple aetiologies.
Red cell production in marrow.
Haemocytoblast - committed cell (proerythroblast)
Developmental - early erythroblast - late erythroblast - noroblast - reticulocyte - erythrocyte (no nucelus)
Substances required for red cell production
Metals: Iron, copper, cobalt, manganese
Vitamins: B12, folic acid, thiamine, Vit.B6, C,E
Amino acids
Hormones: Erythropoietin (made in the kidneys), GM-CSF, androgens, thyroxine, SCF
Red cell breakdown
Normal life span is 120 days. They are normally removed from the circulation and replaced. Magrophages of the reticuloendothelial system (liver and the spleen) breakdown. Globin is re-utlised. The haem is broken down into bilirubin and iron. It is then conjugated in the liver and comes out in the bile and stercobiligin in the stool.
The Red Blood Cell
Biconcave disk, larger surface area for gas transfer and is able to squeeze through small spaces. Contains membrane, enzymes, haemglobin.
Genetic defects in congenital anaemias
Red cell membane, metabolic pathways, haemoglobin. These reduce red cell survival and result in haemolysis. The carrier states are often silent (autosomal recessive).
Red cell membrane
Bilipid layer, intrinsic proteins that help maintain the structure of the cell. Skeletal proteins inside to keep the cell flexible.
Defects in red cell membrane.
Defects in skeletal protiens leading to increased cell destruction. Mutations in Ankyrin, band 3 and spectrin.
Hereditary Spherocytosis
Defects in structural protein resulting in red cells being spherical. These are then removed from circulation by spleen. Leads to anaemia. The most common are autosomal dominant.
Clinical presentation of Herediatry spherocytosis
Anaemia
Jaundice (neonatal)
Splenomegaly
Pigment gallstones (due to increased haemolysis and bilirubin)
Treatment of Hereditary Spherocytosis
Folic acid (increased requirement)
Transfusion (if severe)
Splenectomy (remove the site of production)
Other rare membrane disorders (for information, don’t need to know)
Hereditary Elliptocytosis (ellipotcytes, look like rods) Hereditary Pyropoikilocytosis (cells look an utter mess) South East Asian Ovalocytosis
Red cell enzymes
Glycolysis (production of ADP provides energy for the cell)
Pentose Phosphate Shunt (Protects from oxidative damage)
GLUCOSE 6-PHOSPHATE DEHYDROGENASE
PYRUVATE KINASE
Glucose 6 Phosphate dehydrogenase
Protects red cell proteins (Haemoglobin) from oxidative damage
Produces NADPH - Vital for reduction of glutathione
Reduced glutathione scavenges and detoxifies reactive oxygen species
More likely to break down as a result
G6PD Deficiency
Commonest disease causing enzymopathy in the world
Results in the cells vulnerable to oxidative damage.
X-Linked
Bite cells
Blister cells under the microscope.
Clinical Presentation of G6PD deficiency
Neonatal Jaundice Splenomegaly Pigment Gallstones Intravascular haemolysis Haemoglobinuria
Only really when exposed to infection, acute illness, drugs etc do symptoms occur
Drugs precipitating Haemolysis in G6PD deficiency
Antimalarials
Antibacterials
Analgesics
Antihelminthics
Pyruvate Kinase Deficiency
Reduced ATP, increased 2,3-DPG, cells rigid.
Anaemia, jaundice, gallstones.
Function of haemoglobin
To carry oxygen and facilitate oxygen delivery to the tissues.
Bohr Effect
Acidosis
Hyperthermia
Hypercapnia
Haemoglobin give up oxygen
Normal Adult Haemoglobin
2 Alpha Chains (4 alpha chain genes)
2 Beta Chains (1 beta gene)
HbA (alphaalphabetabeta)
Haemoglobinopathies
Inherited abnormalities of haemoglobin syntesis.
Reduced or absent globin chain production (Thalassaemia)
Point Mutations leading to structurally abnormal globin chain (HbS Sickle Cell anaemia)
Inheritance of Haemoglobinopathies
Autosomal Recessive Inheritance.
Sickle Haemoglobin
2 alpha chains
2 abnormal sickle beta chains.
When it is deoxygenated it crystallises and changes the shape to become a rigid abnormally shaped cell.
Consequences of HbS Polymerisation in Sickle Cell dDisease
Red cell injury, cation loss, dehydration resulting in haemolysis of the red cells.
Endothelial activation
Promotion of inflammation
Coagulation activation
Dysregulation of vasomotor tone by vasodilator mediators (NO) ALL RESULTING in VASO-OCCLUSION
Sickle Cell Disease Clinical Presentation
Painful Vaso-Occlusive Crises (bone pain)
Chest crises
Stroke
Increased infection risk (hyposplenism due to autoinfarction)
Chronic haemolytic anaemia (gallstones, aplastic crisis)
Sequestration Crises (when blood pools in the liver or spleen resulting in redution in blood volume)
Sickle Cell Painful Crises
Severe pain which often requires Opiates (30 minutes of presentation), hydration, oxygen, consider antibiotics (crises triggered by infection)
Sickle Cell Chest Crises Presentation
Chest Pain
Fever
Worsening hypoxia
Infiltrates on CXRay
Chest Crises Treatment
Respiratory support Antibiotics IV fluids Analgesia Transfusion - top up or exchange target HbS <30%.
Life long prophylaxis of Sickle Cell Disease
Vaccination
Penicillin prophylaxis
Folic Acid
Other management of Sickle Cell Disease
Blood transfusion
Hydroxycarbamide
Bone marrow transplantation
Gene Therapy
Thalassaemias
Reduced or absent globin chain production. Mutations or deletions in genes. Chain imbalance results in chronic haemolysis and anaemia.
Homoygous alpha zero thalassaemia (alpha0/alpha0)
No alpha chains Hydrops Fetalis (incompatible with life)
Thalassaemia Major
No beta chains
Transfusion dependent anaemia